EUVIMEDEUVIMED entdecken
Crossref

A Polymeric mRNA Vaccine Featuring Enhanced Site‐Specific mRNA Delivery and Inherent STING‐Stimulating Performance for Tumor Immunotherapy

Xiaoya Guo, Zhiyu Yang, Zhaopei Guo, Huiyan Lai, Hanyu Meng, Meng Meng, Tong Li, Zhen Li, Jie Chen, Yuanji Feng, Xuan Pang, Huayu Tian iD und 1 weitere

Advanced Materials · 2025-04 · 37 (17)

DOI: 10.1002/adma.202410998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 17.03.2025. Verfasst von Xiaoya Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, RNA, Messenger, Membrane Proteins. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, The talent cultivation project Funds for the Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of mRNA delivery carriers with innate immune stimulation functions has emerged as a focal point in the field of mRNA vaccines. Nonetheless, the expression of mRNA in specific sites and innate immune stimulation at specific sites are prerequisites for ensuring the safety of mRNA vaccines. Based on the synthetic PEIRs carriers library, this study identifies an innovative mRNA delivery carrier named POctS with the following characteristics: 1) simultaneously possessing high mRNA delivery efficiency and stimulator of interferon genes (STING) stimulation function. 2) Leveraging the distinctive site‐specific delivery capabilities of POctS, the expression of mRNA at specific sites and the activation of innate immune responses at designated sites are achieved, minimizing formulation toxicity and maximizing the vaccine performance. 3) Tailoring two types of mRNA vaccines based on POctS according to the immune infiltration status of different types of tumors. Briefly, POctS‐loading ovalbumin (OVA) mRNA as a tumor antigen vaccine achieves the prevention and treatment of melanoma in mice. Further, POctS‐loading mixed lineage kinase domain‐like protein (MLKL) mRNA as an in situ tumor vaccine effectively treats orthotopic pancreatic cancer in mice. This delivery carrier offers a feasible mRNA vaccine‐based immunotherapy strategy for various types of tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesImmunotherapyRNA, MessengerMembrane ProteinsmRNA VaccinesPolymersAnimalsMiceHumansMice, Inbred C57BLOvalbuminCell Line, TumorFemaleDrug Carriers

Stichwörter der Autor:innen

STING‐stimulatingcancer immunotherapymRNA vaccinessite‐specific delivery

Substanzen

Cancer VaccinesRNA, MessengerMembrane ProteinsmRNA VaccinesPolymersOvalbuminDrug Carriers

Autor:innen und Institutionen

  • Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
  • State Key Laboratory of Physical Chemistry of Solid Surfaces, College of Chemistry and Chemical Engineering, Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province (IKKEM), Xiamen Uni…

ORCID-Profile: Huayu Tian

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • The talent cultivation project Funds for the Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province

Zitieren

APA

Guo, X., Yang, Z., Guo, Z., Lai, H., Meng, H., Meng, M., Li, T., Li, Z., Chen, J., Feng, Y., Pang, X., Tian, H., & Chen, X. (2025). A Polymeric mRNA Vaccine Featuring Enhanced Site‐Specific mRNA Delivery and Inherent STING‐Stimulating Performance for Tumor Immunotherapy. Advanced Materials, 37(17). https://doi.org/10.1002/adma.202410998

Vancouver

Guo X, Yang Z, Guo Z, Lai H, Meng H, Meng M, et al. A Polymeric mRNA Vaccine Featuring Enhanced Site‐Specific mRNA Delivery and Inherent STING‐Stimulating Performance for Tumor Immunotherapy. Advanced Materials. 2025;37(17). doi:10.1002/adma.202410998

BibTeX
@article{Guo2025,
  author = {Guo, Xiaoya and Yang, Zhiyu and Guo, Zhaopei and Lai, Huiyan and Meng, Hanyu and Meng, Meng and Li, Tong and Li, Zhen and Chen, Jie and Feng, Yuanji and Pang, Xuan and Tian, Huayu and Chen, Xuesi},
  title = {A Polymeric mRNA Vaccine Featuring Enhanced Site‐Specific mRNA Delivery and Inherent STING‐Stimulating Performance for Tumor Immunotherapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {17},
  doi = {10.1002/adma.202410998}
}
Kostenlos starten →